Krammer, Florian

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

Alsoussi, W. B., Turner, J. S., Case, J. B., Zhao, H., Schmitz, A. J., Zhou, J. Q., Chen, R. E., Lei, T., Rizk, A. A., McIntire, K. M., et al. (2020) · The Journal of Immunology

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 181

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

Dugan, H. L., Stamper, C. T., Li, L., Changrob, S., Asby, N. W., Halfmann, P. J., Zheng, N.-Y., Huang, M., Shaw, D. G., Cobb, M. S., et al. (2021) · Immunity

SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell Immunology

Cited by 134

Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine

Krammer, F., Srivastava, K., the PARIS team, & Simon, V. (2021) · medRxiv

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 116

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

Lee, W. T., Girardin, R. C., Dupuis, A. P., Kulas, K. E., Payne, A. F., Wong, S. J., Arinsburg, S., Nguyen, F. T., Mendu, D. R., Firpo-Betancourt, A., et al. (2021) · The Journal of Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 93

Correlates of protection from SARS-CoV-2 infection

Krammer, F. (2021) · The Lancet

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 89

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

Ying, B., Whitener, B., VanBlargan, L. A., Hassan, A. O., Shrihari, S., Liang, C.-Y., Karl, C. E., Mackin, S., Chen, R. E., Kafai, N. M., et al. (2022) · Science Translational Medicine

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 85

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

Asthagiri Arunkumar, G., Ioannou, A., Wohlbold, T. J., Meade, P., Aslam, S., Amanat, F., Ayllon, J., García-Sastre, A., & Krammer, F. (2019) · Journal of Virology

Influenza Virus Research StudiesMonoclonal and Polyclonal Antibodies Research

Cited by 80

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

Schmitz, A. J., Turner, J. S., Liu, Z., Aziati, I. D., Chen, R. E., Joshi, A., Bricker, T. L., Darling, T. L., Adelsberg, D. C., Alsoussi, W. B., et al. (2021) · Immunity

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 72

Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection

de Vries, R. D., Nieuwkoop, N. J., Pronk, M., de Bruin, E., Leroux-Roels, G., Huijskens, E. G. W., van Binnendijk, R. S., Krammer, F., Koopmans, M. P. G., & Rimmelzwaan, G. F. (2017) · Vaccine

Influenza Virus Research StudiesMonoclonal and Polyclonal Antibodies Research

Cited by 63

Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk–Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity

de Vries, R. D., Nieuwkoop, N. J., van der Klis, F. R. M., Koopmans, M. P. G., Krammer, F., & Rimmelzwaan, G. F. (2018) · The Journal of Infectious Diseases

Influenza Virus Research StudiesRespiratory viral infections research

Cited by 39

A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy

Moore, K. A., Leighton, T., Ostrowsky, J. T., Anderson, C. J., Danila, R. N., Ulrich, A. K., Lackritz, E. M., Mehr, A. J., Baric, R. S., Baylor, N. W., et al. (2023) · Vaccine

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 25